c-MET Inhibitor in Advanced Solid Tumors With c-MET Gene Aberration
Clinical trial NCT05882292 · RECRUITING
Trial details
- NCT number
- NCT05882292
- Sponsor
- Yonsei University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-10
- Primary completion
- 2025-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.